Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and preparation method thereof

A technology for doxorubicin hydrochloride and gel preparations, which is applied in the field of doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparations and its preparation, achieving the effects of reducing the number of medications, easy industrialization, and low equipment and raw material costs

Active Publication Date: 2018-07-24
武汉百纳礼康生物制药有限公司
View PDF3 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far, there is still no ideal drug that can reduce the toxicity of doxorubicin while maintaining or enhancing its efficacy, and release the drug on demand according to the patient's condition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and preparation method thereof
  • Doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and preparation method thereof
  • Doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A light-controlled sustained-release liquid crystal gel preparation of doxorubicin hydrochloride, which is prepared from the following raw materials in percentage by weight: 25.99% phosphatidylcholine, 60% glyceryl dioleate, 13.88% absolute ethanol, and doxorubicin hydrochloride 0.1%, IR8200.03%.

[0038] The preparation method of the doxorubicin hydrochloride light-controlled slow-release liquid crystal gel preparation is as follows: after mixing phosphatidylcholine, diolein glyceride, doxorubicin hydrochloride and IR820 according to the weight percentage, then add the The absolute ethanol in the weight percentage is mixed evenly on a mixer to make it completely dissolved, and the doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation is obtained, which is sealed and stored at 4°C.

[0039] The appearance of the product obtained in this example is a light yellow transparent solution, which shows that each raw material has good compa...

Embodiment 2

[0042] A doxorubicin hydrochloride light-controlled slow-release liquid crystal gel preparation, prepared from the following raw materials in weight percentage: 35% phosphatidylcholine, 52% glyceryl dioleate, 12.12% absolute ethanol, doxorubicin hydrochloride 0.8%, IR8200.08%.

[0043] The preparation method is the same as in Example 1.

[0044] The appearance of the product obtained in this example is a light yellow transparent solution, which shows that each raw material has good compatibility and is evenly mixed. There is no delamination phenomenon after storage at -4°C for 6 months and centrifugation treatment, indicating that the product has good storage stability.

[0045] In this example, the cumulative release rate of doxorubicin hydrochloride in the light-controlled sustained-release liquid crystal gel preparation precursor of doxorubicin hydrochloride within one week without and with light were 10.05±0.43% and 22.25±0.21%, respectively. The results are as follows ...

Embodiment 3

[0047] A light-controlled sustained-release liquid crystal gel preparation of doxorubicin hydrochloride, which is prepared from the following raw materials in percentage by weight: phosphatidylcholine 25%, glyceryl dioleate 54.45%, absolute ethanol 20%, doxorubicin hydrochloride 0.5%, IR8200.05%.

[0048] The preparation method is the same as in Example 1.

[0049] The appearance of the product obtained in this example is a light yellow transparent solution, which shows that each raw material has good compatibility and is evenly mixed. There is no delamination phenomenon after storage at -4°C for 6 months and centrifugation treatment, indicating that the product has good storage stability.

[0050] In this embodiment, the cumulative release rate of doxorubicin hydrochloride in the precursor of doxorubicin hydrochloride light-controlled slow-release liquid crystal gel preparation is about 21.15±0.18% within a week without and with light, and the results are as follows image ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and a preparation method thereof. The light-controlled sustained-release liquid crystal gel preparation is prepared from 15-40 wt% of phospholipid, 60-70 wt% of glyceride, 1-20 wt% of a cosolvent, 0.01-2 wt% of doxorubicin hydrochloride and 0.001-0.2 wt% of a photosensitizer. The doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation has the advantages of low viscosity, good fluidity, easiness in injection, rapidness in formation of the liquid crystal gel after being injected into or around a tumor or being placed in a post-operative tumor cavity, and realization of in-situ slow release of doxorubicin hydrochloride; and lights cause phase change of the liquid crystal gel and increase the drug release rate, and the preparation prolongs the drug action time, reduces the administration frequency, reduces the toxic and side effects of the drug, releases the drug as needed by adjusting the release of the drug through adjusting the illumination frequency or time according to the tumor pathological conditions of a patient, and greatly improves the bioavailability of the drug.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a doxorubicin hydrochloride light-controlled sustained-release liquid crystal gel preparation and a preparation method thereof. Background technique [0002] Lyotropic liquid crystals are mainly an ordered system formed by one or more amphiphilic compounds and solvents. There are lattices inside. The orderly arrangement of lattices and the strong interaction between amphiphiles make them It is gel-like in appearance. Lyotropic liquid crystals have attracted the attention of many scientists due to their own structural characteristics, and are gradually used as carriers of various drugs, which can achieve long-term sustained release of various polar drugs in the body. [0003] Doxorubicin is an anthracycline antitumor antibiotic, which can inhibit the synthesis of RNA and DNA, thereby preventing the growth of tumor cells. It has a wide antitumor spectrum and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/704A61K41/00A61P35/00
CPCA61K9/0019A61K9/06A61K31/704A61K41/0052A61K41/0057
Inventor 罗亮王修霞孟凡玲
Owner 武汉百纳礼康生物制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com